Related references
Note: Only part of the references are listed.Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
Eleni Anastasiadou et al.
LEUKEMIA (2019)
Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis
Satoshi Nozuma et al.
FRONTIERS IN MICROBIOLOGY (2019)
Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruption
Barbara Serafini et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis
Caterina Veroni et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells
Asma Hassani et al.
PLOS ONE (2018)
Could antiretrovirals be treating EBV in MS? A case report
Natalia C. Drosu et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis
David Baker et al.
BRAIN (2018)
Epstein-Barr virus: From kisses to cancer, an ingenious immune evader
Pankaj Trivedi et al.
Oncotarget (2018)
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis
Michael P. Pender et al.
JCI INSIGHT (2018)
Molecular signature of Epstein-Barr virus infection in MS brain lesions
Monica A. Moreno et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas
Aaron Goodman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Tomas Olsson et al.
NATURE REVIEWS NEUROLOGY (2017)
Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus
Maria T. Cencioni et al.
IMMUNOLOGY (2017)
Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal
Barbara Serafini et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity
Manuel Albanese et al.
JOURNAL OF VIROLOGY (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years
Sergio E. Baranzini et al.
TRENDS IN GENETICS (2017)
Trials of antivirals in the treatment of multiple sclerosis
J. Lycke
ACTA NEUROLOGICA SCANDINAVICA (2017)
Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients
Gijsbert P. van Nierop et al.
ACTA NEUROPATHOLOGICA (2017)
Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis
Michael P. Pender et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)
Antivirus immune activity in multiple sclerosis correlates with MRI activity
L. B. Latham et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Intrathecal CD4+ and CD8+ T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients
Gijsbert P. van Nierop et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins
Gijsbert P. van Nierop et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins
Gijsbert P. van Nierop et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
The immunology of Epstein-Barr Virus Induced Disease
Graham S. Taylor et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction
Archana Panikkar et al.
JOURNAL OF VIROLOGY (2015)
Anti-CD20 antibody wows in multiple sclerosis
Cormac Sheridan
NATURE BIOTECHNOLOGY (2015)
High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells
Andreas Lossius et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Epstein-Barr Virus in the Central Nervous System and Cervical Lymph Node of a Patient With Primary Progressive Multiple Sclerosis
Barbara Serafini et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Epstein-Barr Virus: The Path from Association to Causality for a Ubiquitous Human Pathogen
Bill Sugden
PLOS BIOLOGY (2014)
Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain
Barbara Serafini et al.
BRAIN (2013)
CD8+ T cells in multiple sclerosis
Aleksandar Denic et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Environmental factors in multiple sclerosis
Alberto Ascherio
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
Epstein-Barr virus and multiple sclerosis: association or causation?
Julia Pakpoor et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
B-Cell Enrichment and Epstein-Barr Virus Infection in Inflammatory Cortical Lesions in Secondary Progressive Multiple Sclerosis
Roberta Magliozzi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Increased CD8+T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
Daniela F. Angelini et al.
PLOS PATHOGENS (2013)
Local CD4 and CD8 T-Cell Reactivity to HSV-1 Antigens Documents Broad Viral Protein Expression and Immune Competence in Latently Infected Human Trigeminal Ganglia
Monique van Velzen et al.
PLOS PATHOGENS (2013)
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
Ken T. Coppieters et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis
Samantha Jilek et al.
JOURNAL OF IMMUNOLOGY (2012)
Persistence of Epstein-Barr Virus in Self-Reactive Memory B Cells
Sean I. Tracy et al.
JOURNAL OF VIROLOGY (2012)
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions
J. S. Tzartos et al.
NEUROLOGY (2012)
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria
Hans Lassmann et al.
BRAIN (2011)
Epstein-Barr virus and multiple sclerosis
R. M. Lucas et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Primary Infection with the Epstein-Barr Virus and Risk of Multiple Sclerosis
Lynn I. Levin et al.
ANNALS OF NEUROLOGY (2010)
Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
Laura Piccio et al.
ARCHIVES OF NEUROLOGY (2010)
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis
Laura A. N. Peferoen et al.
BRAIN (2010)
Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look
Francesca Aloisi et al.
BRAIN (2010)
Upregulation of Immunoglobulin-related Genes in Cortical Sections from Multiple Sclerosis Patients
Oivind Torkildsen et al.
BRAIN PATHOLOGY (2010)
Intrathecal immune responses to EBV in early MS
Emilie Jaquiery et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation
Barbara Serafini et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis
S. A. Sargsyan et al.
NEUROLOGY (2010)
An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
Adam E. Handel et al.
PLOS ONE (2010)
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain
Simon N. Willis et al.
BRAIN (2009)
Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis
M. P. Pender et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders
H. F. Petereit et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
Samantha Jilek et al.
BRAIN (2008)
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
Jan D. Luenemann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis
J. D. Luenemann et al.
NEUROLOGY (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
Barbara Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Increased frequency and broadened specificity of latent EBV nuclear antigen-I-specific T cells in multiple sclerosis
Jan D. Lunemann et al.
BRAIN (2006)
Epstein-Barr virus and multiple sclerosis - Evidence of association from a prospective study with long-term follow-up
Gerald N. DeLorenze et al.
ARCHIVES OF NEUROLOGY (2006)
Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis
LI Levin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells
VA Pudney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
An altered immune response to Epstein-Barr virus in multiple sclerosis -: A prospective study
P Sundström et al.
NEUROLOGY (2004)
Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis
P Höllsberg et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
MP Pender
TRENDS IN IMMUNOLOGY (2003)
A functional and structural basis for TCR cross-reactivity in multiple sclerosis
HLE Lang et al.
NATURE IMMUNOLOGY (2002)
Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
H Babbe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
